Higher resistance to cancer treatment has been linked to the presence of key regulators of strain self-renewal, including octamer-binding transcription factor 4 (OCT4), sex-determining region Y-box 2 (SOX2), and the Nanog homeobox (NANOG) [2, 3]. The gene discussed is NANOG; the disease is cancer.